We are live on ! Find out more
RIGL icon

Rigel Pharmaceuticals
RIGL

193 hedge funds and large institutions have $691M invested in Rigel Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 67 increasing their positions, 62 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

320% more call options, than puts

Call options by funds: $7.71M | Put options by funds: $1.84M

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

96% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 26

62% more capital invested

Capital invested by funds: $426M → $691M (+$265M)

14% more funds holding

Funds holding: 169 → 193 (+24)

5.17% more ownership

Funds ownership: 83.75% → 88.92% (+5.2%)

8% more repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 62

Holders
193
Holders Change
+24
Holders Change %
+14.2%
% of All Funds
2.35%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.02%
New
51
Increased
67
Reduced
62
Closed
26
Calls
$7.71M
Puts
$1.84M
Net Calls
+$5.87M
Net Calls Change
+$5.32M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$20.2M
2
LSV Asset Management
LSV Asset Management
Illinois
+$16.3M
3
Millennium Management
Millennium Management
New York
+$12.3M
4
American Century Companies
American Century Companies
Missouri
+$9.59M
5
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$8.57M

Top Sellers

Rank Fund Capital Flow
1
CLGM
Capitolis Liquid Global Markets
New York
-$16.8M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$7.33M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$7.24M
4
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
-$4.54M
5
Squarepoint
Squarepoint
New York
-$4.49M
Name Holding Trade Value Shares
Change 		Change in
Stake
Massachusetts Financial Services
51
Massachusetts Financial Services
Massachusetts
$2.27M -$66K -1,752 -3%
HSA
52
Hussman Strategic Advisors
Maryland
$2.25M +$1.98M +52,500 New
HWAM
53
Hennion & Walsh Asset Management
New Jersey
$2.24M +$1.97M +52,189 New
WP
54
Woodline Partners
California
$2.14M +$1.88M +50,000 New
Los Angeles Capital Management
55
Los Angeles Capital Management
California
$2.09M -$114K -3,013 -4%
UBS Group
56
UBS Group
Switzerland
$1.99M -$2.04M -54,159 -54%
RFG
57
Range Financial Group
Oregon
$1.97M +$21.1K +561 +1%
Jacobs Levy Equity Management
58
Jacobs Levy Equity Management
New Jersey
$1.91M -$236K -6,259 -12%
Raymond James Financial
59
Raymond James Financial
Florida
$1.87M +$8.9K +236 +0.5%
ASN
60
Advisory Services Network
Georgia
$1.87M +$450K +11,945 +38%
Rafferty Asset Management
61
Rafferty Asset Management
New York
$1.85M +$1.11M +29,421 +215%
Franklin Resources
62
Franklin Resources
California
$1.76M +$167K +4,430 +12%
RL
63
Ruffer LLP
United Kingdom
$1.6M +$1.4M +37,244 New
SBH
64
Segall Bryant & Hamill
Illinois
$1.6M +$47.3K +1,255 +3%
JP Morgan Chase
65
JP Morgan Chase
New York
$1.59M +$77.4K +2,054 +6%
Janus Henderson Group
66
Janus Henderson Group
United Kingdom
$1.55M -$7.33M -194,504 -84%
BNP Paribas Asset Management
67
BNP Paribas Asset Management
France
$1.5M +$1.32M +35,029 New
Invesco
68
Invesco
Georgia
$1.5M +$256K +6,790 +24%
DP
69
Diadema Partners
New Jersey
$1.28M +$1.13M +30,000 New
Credit Agricole
70
Credit Agricole
France
$1.23M +$1.09M +28,800 New
YIH
71
Y-Intercept (HK)
Hong Kong
$1.21M +$167K +4,440 +19%
AA
72
ALPS Advisors
Colorado
$1.16M +$249K +6,611 +32%
EI
73
EAM Investors
California
$1.16M -$337K -8,932 -25%
SEI Investments
74
SEI Investments
Pennsylvania
$1.15M -$1.25M -33,216 -55%
WAM
75
Wakefield Asset Management
Colorado
$1.1M +$967K +25,651 New
1 2
3
4 5

RIGL Hedge Fund Activity: Q4 2025 in Review

193 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Rigel Pharmaceuticals (RIGL) for Q4 2025, worth a combined $691M — up 62% from $426M a quarter earlier.

Buyers outnumbered sellers: 51 funds opened new RIGL positions and 26 closed out — a net gain of 25 holders — while 67 added to existing stakes and 62 trimmed.

The largest buyer was State Street, adding an estimated $20.2M. The largest seller was Capitolis Liquid Global Markets, exiting entirely with an estimated $16.8M sold.

  • 193 institutional investors held Rigel Pharmaceuticals (RIGL) as of Q4 2025, up from 169 in Q3 2025.
  • Funds reported $691M of Rigel Pharmaceuticals stock for Q4 2025, up 62% quarter-over-quarter.
  • 51 funds opened new Rigel Pharmaceuticals positions in Q4 2025 and 26 closed out, a net change of +25 holders.
  • The largest Rigel Pharmaceuticals buyer in Q4 2025 was State Street, an estimated $20.2M added.
  • The largest Rigel Pharmaceuticals seller in Q4 2025 was Capitolis Liquid Global Markets, an estimated $16.8M sold.

Based on aggregated 13F filings for Q4 2025.